No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

14 trials linked to this intervention

Total Trials

Recruiting

With Results

Recent Trials

Recurrent Throat Infections and Tonsillectomy

NCT00547391Phase 4Completed87 enrolled

Post Operative Sore Throat and Dexamethasone

NCT01052038Phase 4Completed120 enrolled

Efficacy of Tinoridine in Treating Pain and Inflammation in Adults

NCT01224756Phase 4Completed342 enrolled

Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies

NCT01363531Phase 4Completed405 enrolled

Impact of Four Patient Information Leaflets (PIL) on Patient Behaviour

NCT01398696Phase 4Completed400 enrolled

View all 14 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

A prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis.

Monmaturapoj Teerapong, Montakantikul Preecha, Mootsikapun Piroon et al. · Int J Infect Dis · 2012

PMID: 22951426RCT

In vitro Activity of Cefditoren against Middle Ear Fluid Isolates from Costa Rican Children with Otitis Media.

Ulloa Catalina, Guevara Silvia, Soley Carolina et al. · Chemotherapy · 2014

PMID: 25871785Trial

Five-day oral cefditoren pivoxil versus 10-day oral amoxicillin for pediatric group A streptococcal pharyngotonsillitis.

Ozaki Takao, Nishimura Naoko, Suzuki Michio et al. · J Infect Chemother · 2008

PMID: 18574657Trial

Use of population pharmacokinetic modeling and Monte Carlo simulation to describe the pharmacodynamic profile of cefditoren in plasma and epithelial lining fluid.

Lodise Thomas P, Kinzig-Schippers Martina, Drusano George L et al. · Antimicrob Agents Chemother · 2008

PMID: 17485507TrialFull text (PMC)

Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.

Sádaba Belen, Azanza J R, Quetglas E G et al. · Rev Esp Quimioter · 2007

PMID: 17530036Trial

Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.

Alvarez-Sala Jose-Luis, Kardos Peter, Martínez-Beltrán Jesús et al. · Antimicrob Agents Chemother · 2006

PMID: 16641447TrialFull text (PMC)

Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil.

Brass Eric P, Mayer Michael D, Mulford Darcy J et al. · Clin Pharmacol Ther · 2003

PMID: 12709724Trial

Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.

Bucko Alicia D, Hunt Barbara J, Kidd Sarah L et al. · Clin Ther · 2002

PMID: 12182257Trial

A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.

Fogarty Charles M, Cyganowski Marcia, Palo William A et al. · Clin Ther · 2002

PMID: 12501879Trial

Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.

van Zyl Louis, le Roux Jacobus G, LaFata John A et al. · Clin Ther · 2002

PMID: 12501878Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Cefditoren (substance)
SNOMED CT: 708598002
UMLS CUI: C0287573
RxNorm CUI: 83682

Clinical Data

This intervention maps to 9 entities in the Ltrl knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.